{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:32:34Z","timestamp":1770010354851,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s12149-007-0125-9","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T08:00:16Z","timestamp":1212652816000},"page":"261-267","source":"Crossref","is-referenced-by-count":33,"title":["Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings"],"prefix":"10.1007","volume":"22","author":[{"given":"Keisuke","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hatazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,6]]},"reference":[{"key":"125_CR1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"52","author":"P. Isaacson","year":"1983","unstructured":"Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983;52:1410\u20131416.","journal-title":"Cancer"},{"key":"125_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/asheducation-2001.1.241","volume":"1","author":"F. Cavalli","year":"2001","unstructured":"Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 2001;1:241\u2013258.","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"125_CR3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C. Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000;95:802\u2013806.","journal-title":"Blood"},{"key":"125_CR4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1368-8375(98)00050-5","volume":"34","author":"M.P. Stokkel","year":"1998","unstructured":"Stokkel MP, ten Broek FW, van Rijk PP. The role of FDG PET in the clinical management of head and neck cancer. Oral Oncol 1998;34:466\u2013471.","journal-title":"Oral Oncol"},{"key":"125_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0001-2998(98)80034-2","volume":"28","author":"F.L. Flanagan","year":"1998","unstructured":"Flanagan FL, Dehdashti F, Siegel BA. PET in breast cancer. Semin Nucl Med 1998;28:290\u2013302.","journal-title":"Semin Nucl Med"},{"key":"125_CR6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/snuc.2000.7439","volume":"30","author":"R. Bar-Shalom","year":"2000","unstructured":"Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150\u2013185.","journal-title":"Semin Nucl Med"},{"key":"125_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/snuc.2002.29272","volume":"32","author":"R. Hustinx","year":"2002","unstructured":"Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 2002;32:35\u201346.","journal-title":"Semin Nucl Med"},{"key":"125_CR8","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","volume":"101","author":"R. Elstrom","year":"2003","unstructured":"Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101:3875\u20133876.","journal-title":"Blood"},{"key":"125_CR9","first-page":"343","volume":"38","author":"C.K. Hoh","year":"1997","unstructured":"Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, et al. Whole-body FDG-PET imaging for staging of Hodgkin\u2019s disease and lymphoma. J Nucl Med 1997;38:343\u2013348.","journal-title":"J Nucl Med"},{"key":"125_CR10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1023\/A:1008327127033","volume":"10","author":"P.L. Zinzani","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Chierichetti F, Zompatori M, Garraffa G, Bendandi M, et al. The role of positron emission tomography (PET) in the management of lymphoma patients. Ann Oncol 1999;10:1181\u20131184.","journal-title":"Ann Oncol"},{"key":"125_CR11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","volume":"19","author":"K. Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxy-glucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin\u2019s lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001;19: 414\u2013419.","journal-title":"J Clin Oncol"},{"key":"125_CR12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2004.05069.x","volume":"126","author":"C. Burton","year":"2004","unstructured":"Burton C, Ell P, Linch D. The role of PET imaging in lymphoma. Br J Haematol 2004;126:772\u2013784.","journal-title":"Br J Haematol"},{"key":"125_CR13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000070290","volume":"64","author":"M. Hoffmann","year":"2003","unstructured":"Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 2003;64:336\u2013340.","journal-title":"Oncology"},{"key":"125_CR14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdi093","volume":"16","author":"K.P. Beal","year":"2005","unstructured":"Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005; 16:473\u2013480.","journal-title":"Ann Oncol"},{"key":"125_CR15","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1080\/10428190600733499","volume":"47","author":"L. Alinari","year":"2006","unstructured":"Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2006;47:2096\u20132101.","journal-title":"Leuk Lymphoma"},{"key":"125_CR16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.annonc.a058390","volume":"4","author":"B.G. Taal","year":"1993","unstructured":"Taal BG, Burgers JM, van Heerde P, Hart AA, Somers R. The clinical spectrum and treatment of primary non-Hodgkin\u2019s lymphoma of the stomach. Ann Oncol 1993;4:839\u2013846.","journal-title":"Ann Oncol"},{"key":"125_CR17","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"N.R. Schechter","year":"1998","unstructured":"Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998;16:1916\u20131921.","journal-title":"J Clin Oncol"},{"key":"125_CR18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00259-002-0924-0","volume":"29","author":"M. Hickeson","year":"2002","unstructured":"Hickeson M, Yun M, Matthies A, Zhuang H, Adam LE, Lacorte L, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging 2002;29:1639\u20131647.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"125_CR19","first-page":"1519","volume":"45","author":"R. Boellaard","year":"2004","unstructured":"Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004;45:1519\u20131527.","journal-title":"J Nucl Med"},{"key":"125_CR20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2141.2001.03169.x","volume":"115","author":"K. Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, Thomas J, Vandenberghe P, Balzarini J, et al. Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin\u2019s disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br J Haematol 2001;115:272\u2013278.","journal-title":"Br J Haematol"},{"key":"125_CR21","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","volume":"17","author":"M. Hoffmann","year":"2006","unstructured":"Hoffmann M, Wohrer S, Becherer A, Chott A, Streubel B, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann Oncol 2006;17:1761\u20131765.","journal-title":"Ann Oncol"},{"key":"125_CR22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF02984984","volume":"17","author":"H. Koga","year":"2003","unstructured":"Koga H, Sasaki M, Kuwabara Y, Hiraka K, Nakagawa M, Abe K, et al. An analysis of the physiological FDG uptake pattern in the stomach. Ann Nucl Med 2003;17:733\u2013738.","journal-title":"Ann Nucl Med"},{"key":"125_CR23","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1053\/gast.1997.v112.pm9178679","volume":"112","author":"P. Neumeister","year":"1997","unstructured":"Neumeister P, Hoefler G, Beham Schmid C, Schmit H, Apfelbeck U, Schaider H, et al. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa associated lymphoid tissue lymphomas. Gastroenterology 1997;112:1871\u20131875.","journal-title":"Gastroenterology"},{"key":"125_CR24","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood.V86.12.4587.bloodjournal86124587","volume":"86","author":"M. Du","year":"1995","unstructured":"Du M, Peng H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995;86:4587\u20134593.","journal-title":"Blood"},{"key":"125_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1470-2045(02)00651-4","volume":"3","author":"M.Q. Du","year":"2002","unstructured":"Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002;3:97\u2013104.","journal-title":"Lancet Oncol"},{"key":"125_CR26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0969-8051(98)00038-9","volume":"25","author":"A. Waki","year":"1998","unstructured":"Waki A, Kato H, Yano R, Sadato N, Yokoyama A, Ishii Y, et al. The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro. Nucl Med Biol 1998;25:593\u2013597.","journal-title":"Nucl Med Biol"},{"key":"125_CR27","first-page":"1811","volume":"36","author":"T. Torizuka","year":"1995","unstructured":"Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995;36:1811\u20131817.","journal-title":"J Nucl Med"},{"key":"125_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02988530","volume":"17","author":"H. Koga","year":"2003","unstructured":"Koga H, Matsuo Y, Sasaki M, Nakagawa M, Kaneko K, Hayashi K, et al. Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma. Ann Nucl Med 2003;17:327\u2013331.","journal-title":"Ann Nucl Med"},{"key":"125_CR29","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdf256","volume":"13","author":"K. Spaepen","year":"2002","unstructured":"Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol 2002;13:1356\u20131363.","journal-title":"Ann Oncol"},{"key":"125_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/10428190009113384","volume":"39","author":"N.G. Mikhaeel","year":"2000","unstructured":"Mikhaeel NG, Timothy AR, O\u2019Doherty MJ, Hain S, Maisey MN. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin\u2019s lymphoma-comparison with CT. Leuk Lymphoma 2000;39:543\u2013553.","journal-title":"Leuk Lymphoma"},{"key":"125_CR31","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","volume":"16","author":"N.G. Mikhaeel","year":"2005","unstructured":"Mikhaeel NG, Hutchings M, Fields PA, O\u2019Doherty MJ, Timothy AR. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 2005;16:1514\u20131523.","journal-title":"Ann Oncol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-007-0125-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0125-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T05:08:15Z","timestamp":1588741695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-007-0125-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1007\/s12149-007-0125-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}